VBI Vaccines Inc reports results for the quarter ended in September - Earnings Summary

VBI Vaccines

10/11/2022 14:41

* VBI Vaccines Inc  VBIV.OQ  reported a quarterly adjusted
loss
of 9 cents​​ per share for the quarter ended in September. The
mean expectation of three analysts for the quarter was for a
loss of 8 cents per share.
    * Revenue rose 196.3% to $317.00 thousand from a year ago;
analysts expected $1.29 million. 
    * VBI Vaccines Inc's reported EPS for the quarter was a loss
of 9
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * VBI Vaccines Inc shares had fallen by 14.2% this
quarter and
lost 74.1% so far this year.
    * The company reported a quarterly loss of $25.21 million.
    * Wall Street's median 12-month price target for VBI
Vaccines Inc
is $6.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 02:41 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.08          -0.09          Missed
 Jun. 30 2022      -0.07          -0.18          Missed
 Mar. 31 2022      -0.08          -0.08          Met
 Dec. 31 2021      -0.07          -0.07          Met